ECM
NVO

Eisler Capital Management’s Novo Nordisk NVO Stock Holding History

Eisler Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119,500
Closed -$10.5M – 1010
2024
Q4 		$10.5M Buy
+119,500
New +$12.9M 0.05% 293

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eisler Capital Management's NVO Position: Q3 2025 in Review

Eisler Capital Management increased its Novo Nordisk (NVO) stake by 189% in Q3 2025, buying an estimated $631K and bringing the position to 16,497 shares worth $909K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Eisler Capital Management first reported a position in NVO in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.34M in Q4 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Eisler Capital Management held 16,497 shares of Novo Nordisk worth $909K as of Q3 2025.
  • Eisler Capital Management bought 10,787 Novo Nordisk shares in Q3 2025, an estimated $631K.
  • Novo Nordisk made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #579 holding.
  • Eisler Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 3 quarters since.
  • Eisler Capital Management's Novo Nordisk position peaked at $1.34M in Q4 2024.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.